BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22320993)

  • 1. Expressional alterations and transcript isoforms of metastasis suppressor genes (KAI1 and KiSS1) in breast cancer patients.
    Mooez S; Malik FA; Kayani MA; Rashid R; Zahid A; Khan A
    Asian Pac J Cancer Prev; 2011; 12(10):2785-91. PubMed ID: 22320993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of germ line changes in KISS1 and KAI1 genes in sporadic head and neck cancer patients of Pakistani origin.
    Nazir M; Kayani MR; Malik FA; Masood N; Kayani MA
    Asian Pac J Cancer Prev; 2011; 12(10):2767-71. PubMed ID: 22320990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases.
    Stark AM; Tongers K; Maass N; Mehdorn HM; Held-Feindt J
    J Cancer Res Clin Oncol; 2005 Mar; 131(3):191-8. PubMed ID: 15592684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancer.
    Christgen M; Bruchhardt H; Ballmaier M; Krech T; Länger F; Kreipe H; Lehmann U
    Int J Cancer; 2008 Nov; 123(10):2239-46. PubMed ID: 18712725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced protein expression of metastasis-related genes (nm23, KISS1, KAI1 and p53) in lymph node and liver metastases of gastric cancer.
    Guan-Zhen Y; Ying C; Can-Rong N; Guo-Dong W; Jian-Xin Q; Jie-Jun W
    Int J Exp Pathol; 2007 Jun; 88(3):175-83. PubMed ID: 17504447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
    Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression pattern of metastasis suppressors KAI1 and KISS1 in endometriosis and normal endometrium.
    Timologou A; Zafrakas M; Grimbizis G; Miliaras D; Kotronis K; Stamatopoulos P; Tarlatzis BC
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():110-5. PubMed ID: 26918694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression Levels of Tetraspanin KAI1/CD82 in Breast Cancers in North Indian Females.
    Singh R; Bhatt ML; Singh SP; Kumar V; Goel MM; Mishra DP; Srivastava K; Kumar R
    Asian Pac J Cancer Prev; 2016; 17(7):3431-6. PubMed ID: 27509988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
    Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
    Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of metastasis suppressor gene KAI1 on the proliferation and invasive ability of cervical carcinoma cells].
    Ouyang YW; Pan XL; Qu Y; Peng ZL; Wei DP; Wang X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):753-6. PubMed ID: 19024306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A twisted kiss: in vitro and in vivo evidence of genetic variation and suppressed transcription of the metastasis-suppressor gene KiSS1 in early breast cancer.
    Pentheroudakis G; Kostadima L; Dova L; Georgiou I; Tzavaras T; Vartholomatos G; Wirtz RM; Fountzilas G; Malamou-Mitsi V; Pavlidis N
    Neoplasma; 2010; 57(1):47-54. PubMed ID: 19895172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of metastasis-associated genes in papilla of vater and pancreatic cancer correlates with disease stage.
    Friess H; Guo XZ; Tempia-Caliera AA; Fukuda A; Martignoni ME; Zimmermann A; Korc M; Büchler MW
    J Clin Oncol; 2001 May; 19(9):2422-32. PubMed ID: 11331321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KAI1 protein is down-regulated during the progression of human breast cancer.
    Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M
    Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor-kappaB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53.
    Shinohara T; Miki T; Nishimura N; Nokihara H; Hamada H; Mukaida N; Sone S
    Cancer Res; 2001 Jan; 61(2):673-8. PubMed ID: 11212267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade.
    Bouras T; Frauman AG
    J Pathol; 1999 Aug; 188(4):382-8. PubMed ID: 10440748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative splicing of KAI1 abrogates its tumor-suppressive effects on integrin αvβ3-mediated ovarian cancer biology.
    Upheber S; Karle A; Miller J; Schlaugk S; Gross E; Reuning U
    Cell Signal; 2015 Mar; 27(3):652-62. PubMed ID: 25435431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer.
    Okugawa Y; Inoue Y; Tanaka K; Toiyama Y; Shimura T; Okigami M; Kawamoto A; Hiro J; Saigusa S; Mohri Y; Uchida K; Kusunoki M
    Oncol Rep; 2013 Sep; 30(3):1449-54. PubMed ID: 23784200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic mutations and expression analysis of spleen tyrosine kinase gene in breast cancer: a preliminary report.
    Inayat U; Kayani MA; Faryal R
    Pol J Pathol; 2012 Jun; 63(2):106-11. PubMed ID: 22864779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of an antibody that can detect the Kai1/CD82 murine metastasis suppressor.
    Custer MC; Risinger JI; Hoover S; Simpson RM; Patterson T; Barrett JC
    Prostate; 2006 May; 66(6):567-77. PubMed ID: 16372335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines.
    You J; Madigan MC; Rowe A; Sajinovic M; Russell PJ; Jackson P
    Urol Oncol; 2012; 30(4):502-8. PubMed ID: 20864363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.